Description
WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Terrapin Pharmacy LLC ("Terrapin" or the "Company"), a leading specialized pharmacy offering high-touch, value-added distribution and medication adherence services and technology. The Company primarily serves patients with severe and persistent mental illness (SPMI), intellectual and developmental disabilities (IDD), and substance abuse disorders. Terms of the transaction were not disclosed.